Sherwood

Latest Stories

tech

OpenAI is now officially showing ads

Just a day after Anthropic’s Super Bowl ad aired, making fun of the concept of ad-backed AI chatbots, OpenAI began testing ads in ChatGPT for its free and Go subscription tiers.

In a blog post, OpenAI reiterated that ads wouldn’t affect ChatGPT’s responses and would be “clearly labeled as sponsored and visually separated from the organic answer.”

“Our goal is for ads to support broader access to more powerful ChatGPT features while maintaining the trust people place in ChatGPT for important and personal tasks,” the company wrote. “We’re starting with a test to learn, listen, and make sure we get the experience right.”

Advertising is one way the company, which is expected to go public late this year, could offset the massive cost of running its service.

The Information previously reported that OpenAI aiming for ad spending commitments of less than a million dollars per advertiser during the testing phase — far cheaper than a Super Bowl prime-time spot like Anthropic’s.

“Our goal is for ads to support broader access to more powerful ChatGPT features while maintaining the trust people place in ChatGPT for important and personal tasks,” the company wrote. “We’re starting with a test to learn, listen, and make sure we get the experience right.”

Advertising is one way the company, which is expected to go public late this year, could offset the massive cost of running its service.

The Information previously reported that OpenAI aiming for ad spending commitments of less than a million dollars per advertiser during the testing phase — far cheaper than a Super Bowl prime-time spot like Anthropic’s.

tech

New study finds AI doesn’t reduce work — it intensifies it

The rapid adoption of AI by businesses was fueled by the promise of huge productivity boosts that could supercharge workers. A new study has found that while it did indeed boost workers’ productivity, the use of generative AI at work also made work more intense and creep into workers’ downtime.

Researchers Aruna Ranganathan and Xingqi Maggie Ye followed about 200 workers at a US tech company for 8 months. They found AI did speed up work, allowing employees to take on more responsibilities. But after the novelty of their newfound superpowers wore off, workers reported “cognitive fatigue, burnout, and weakened decision-making.”

The researchers noted that to avoid AI-inspired burnout and turnover, organizations should adopt an “AI practice,” spelling out how the technology is expected to be used, and what kinds of limits are in place.

Researchers Aruna Ranganathan and Xingqi Maggie Ye followed about 200 workers at a US tech company for 8 months. They found AI did speed up work, allowing employees to take on more responsibilities. But after the novelty of their newfound superpowers wore off, workers reported “cognitive fatigue, burnout, and weakened decision-making.”

The researchers noted that to avoid AI-inspired burnout and turnover, organizations should adopt an “AI practice,” spelling out how the technology is expected to be used, and what kinds of limits are in place.

tech

Report: Anthropic staffing up to build as much as 10 gigawatts worth of data centers

Anthropic has been hiring a team of executives with a very particular set of skills — building huge data centers. The Information is reporting that Anthropic may be planning to build up to 10 gigawatts of AI computing capacity over several years.

According to the report, Anthropic has hired several former Google executives with deep experience building data centers, which aligns with Anthropic’s heavy use of Google’s tensor processing units.

10 gigawatts would be incredibly expensive. OpenAI executives reportedly have said that building a 1-gigawatt data center costs about $50 billion — putting the cost of 10 gigawatts in the ballpark of $500 billion. But Anthropic told investors it would only spend $180 billion on AI computing servers through 2029, according to the story.

In November, Anthropic announced a deal with Fluidstack to build its first data centers, based in New York and Texas, investing $50 billion in the projects. Anthropic is racing alongside OpenAI to pull off an IPO later this year.

10 gigawatts would be incredibly expensive. OpenAI executives reportedly have said that building a 1-gigawatt data center costs about $50 billion — putting the cost of 10 gigawatts in the ballpark of $500 billion. But Anthropic told investors it would only spend $180 billion on AI computing servers through 2029, according to the story.

In November, Anthropic announced a deal with Fluidstack to build its first data centers, based in New York and Texas, investing $50 billion in the projects. Anthropic is racing alongside OpenAI to pull off an IPO later this year.

markets

Sandisk and Micron slip as Samsung rushes new product into production

Sandisk and Micron, which have boomed along with prices for the memory chips needed for the AI data center build-out, are limping behind the broader market Monday after a weekend report that South Korean chip giant Samsung is beginning “mass production” of its latest memory product, HBM4, slightly earlier than expected.

US memory chip maker Micron also makes HBM (high-bandwidth memory), which is essentially a large memory product designed for AI applications.

Sandisk doesn’t make HBM. But it is developing a kind of high-bandwidth flash NAND memory product that is intended to function as an HBM option for AI data centers.

More broadly, signs that Asian production giants are responding to high prices by ramping up supply means that the nosebleed pricing of memory chips that quintupled Sandisk’s profit over the last year might not last forever.

US memory chip maker Micron also makes HBM (high-bandwidth memory), which is essentially a large memory product designed for AI applications.

Sandisk doesn’t make HBM. But it is developing a kind of high-bandwidth flash NAND memory product that is intended to function as an HBM option for AI data centers.

More broadly, signs that Asian production giants are responding to high prices by ramping up supply means that the nosebleed pricing of memory chips that quintupled Sandisk’s profit over the last year might not last forever.

crypto

Meme coins have lost all their 2026 gains and continue to dive

Despite having an early lead in year-to-date gains, meme coins have round-tripped and bled even more. 

For example, frog-based token pepe was up 75% in the first four days of January, but is now about 8% lower than where it started the year. Dogecoin, shiba inu, bonk, pengu, dogwifhat, and trump tell a similar story: posting a positive gain and then slumping into the red. 

Screenshot 2026-02-09 at 11.32.10 AM.png
The year-to-date price performances of the top meme coins by market capitalization (TradingView)

Meme coins, cryptocurrencies based on internet jokes that are often critiqued for lacking utility, are reflexive: they can lead gains during bullish market conditions, but see sharper declines in bearish ones. The entire category of meme coins has shed 25.8% of its valuation in the year so far, data from blockchain analytics firm Artemis shows.

The price action of meme coins comes amid a broader market decline that saw bitcoin drop to $63,000 last week as its peers revisited cycle lows

“The market has, in large, been bleeding, whether major, altcoin, or meme,” according to Nicolai Søndergaard, research analyst at on-chain data firm Nansen. “It is not surprising to me to see that larger memes as well have been trending down.”

He told Sherwood News, “If we also consider the fact that there are less active wallets now compared to a few months ago, it also makes sense that larger ‘household’ memes would decline as money shifts around to the next shiny thing.”

world

Google searches for “roman numerals” hit a new peak this Super Bowl

Following on from last year’s Super Bowl LIX, and Super Bowl LVIII before that, you’d be forgiven for thinking that the title “Super Bowl LX” might have created less confusion than previous iterations.

But it seems that the archaic notation denoting this year’s Big Game was no exception: monthly search volumes for “roman numerals” in the US were at the highest volume seen in over two decades this February, according to Google Trends data.

Roman numerals super bowl
Sherwood News

If people in shoulder pads throwing around a weirdly shaped ball is your Roman Empire, one thing you have to know is Roman numerals — or join the millions who turn to Google to work out how to read them every Super Bowl season.

Ironically, according to the NFL, the numbering system was adopted for clarity, as the game is played at the start of the year “following a chronologically recorded season.” And so, over its 60-year history, the NFL has labeled almost every Super Bowl with a selection of capital letters like X’s, I’s, and V’s — one of the rare exceptions being Super Bowl 50 in 2016, when the NFL ad designers felt Super Bowl L was too unmarketable.

At least stumped football fans in 2026 will be faring much better than those in the year 12,965 would be, who’d have to refer to the Big Game as Super Bowl (breathes in) MMMMMMMMMMDCCCCLXXXXVIIII.

tech

Report: OpenAI tells employees it is growing again, with Codex eating into Claude Code’s market share

The competition between OpenAI and Anthropic continues to intensify. Last night during the Super Bowl, a comedic Anthropic ad poked fun at OpenAI’s plans to add advertisements to ChatGPT, something it says it will not do to its Claude chatbot. And both companies released new models last week with improved coding capabilities.

In case OpenAI employees were beginning to sweat from all the pressure, CEO Sam Altman sought to assure the team that the company has gotten its mojo back.

According a new report from CNBC, Altman told employees in an internal Slack group that the company is “back to exceeding 10% monthly growth” and is seeing “insane” growth in its Codex coding tool.

A chart circulated among OpenAI employees shows that this new tool is winning market share from Claude Code, per a screenshot viewed by CNBC.

Per the report, Altman said another new model was coming this week. The company is reportedly working on what could end being a $100 billion investment round.

In case OpenAI employees were beginning to sweat from all the pressure, CEO Sam Altman sought to assure the team that the company has gotten its mojo back.

According a new report from CNBC, Altman told employees in an internal Slack group that the company is “back to exceeding 10% monthly growth” and is seeing “insane” growth in its Codex coding tool.

A chart circulated among OpenAI employees shows that this new tool is winning market share from Claude Code, per a screenshot viewed by CNBC.

Per the report, Altman said another new model was coming this week. The company is reportedly working on what could end being a $100 billion investment round.

Your inbox is ready

Subscribe and thrive

Snacks provides fresh takes on the financial news you need to start your day. Chartr provides data visualizations on business, entertainment, and society. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

markets

Oracle rises as DA Davidson gives it a “buy” rating because of OpenAI positivity

Oracle rose after receiving an upgrade to start the week. Analysts at DA Davidson bumped up their view on the stock from “neutral” to “buy” and kept their $180 price target on the shares. That’s about 27% higher than Friday’s close.

Their shift isn’t so much about Oracle but about OpenAI, which Davidson folks now think is increasingly likely to be able to make good on billions of dollars’ worth of planned spending on computing power at Oracle and other hyperscalers. They wrote:

We are now more positive on OpenAI, based on changes in strategy, new frontier models, the pressure on Google’s competitors from its recent ascent, and progress on its fundraising efforts. Most importantly, we believe OpenAI already has as much as $40B of cash on hand and may be raising as much as another $100B by the end of the quarter, which should help pay for the data centers Oracle is building for OpenAI. Since the market is currently assigning the OpenAI relationship a negative value, we believe the fundraise will serve as a catalyst for outperformance.

For OpenAI’s part, CEO Sam Altman just told employees that the company was “back to exceeding 10% monthly growth,” according to CNBC reporting.

markets

Roblox rises following upgrade and price target hike from Roth Capital as growth in older players boosts optimism

Shares of Roblox are up in early trading on Monday following a price target hike and an upgrade from “neutral” to “buy” from Roth Capital.

Roth bumped its price target up from $78 to $84, with analyst Eric Handler citing the company’s “sustainable virtuous circle where continuously improving creator/development tools are producing higher quality games, which enhances the user experience, and drives higher engagement.”

Handler also noted Roblox’s success in growing its 18-plus player base, which increased 50% last year and, per Roth, “monetized 40% higher than under-18-users.”

The platform surged after reporting its fourth-quarter earnings last week, with stronger-than-expected full-year bookings guidance. Still, the stock remains below levels in January, before the debut of Google’s AI interactive worlds generator, Project Genie.

tech

Google plans $15 billion US bond sale as capex surges

Alphabet is preparing a roughly $15 billion US investment-grade bond sale, Bloomberg reports, citing people familiar with the deal. The offering is expected to be split into as many as seven tranches, with initial price talk for the longest maturity — a 2066 bond — at about 120 basis points over Treasurys. JPMorgan is leading the sale alongside Goldman Sachs and Bank of America.

In a sign of just how attractive lending money to Alphabet is to investors, the bond sale has already attracted more than $100 billion in orders.

The sale follows Google parent Alphabet’s $17.5 billion US bond deal in November and underscores how even tech companies flush with cash are turning to the bond market to finance their huge AI ambitions. Alphabet expects its capital spending to balloon to $175 billion to $185 billion this year, as it races other tech giants shelling out record sums to get ahead in artificial intelligence. In 2025, the company’s total operating income was $129 billion.

In a sign of just how attractive lending money to Alphabet is to investors, the bond sale has already attracted more than $100 billion in orders.

The sale follows Google parent Alphabet’s $17.5 billion US bond deal in November and underscores how even tech companies flush with cash are turning to the bond market to finance their huge AI ambitions. Alphabet expects its capital spending to balloon to $175 billion to $185 billion this year, as it races other tech giants shelling out record sums to get ahead in artificial intelligence. In 2025, the company’s total operating income was $129 billion.

tech

EU wants Meta to open up access to rival AI chatbots through WhatsApp

The European Union threatened Meta with “interim measures” if it continues to block rival AI assistants from operating on WhatsApp, escalating regulatory pressure on the company’s strategy in Europe. Meta said there was “no reason for the EU to intervene in the WhatsApp Business API,” arguing that its policy does not stifle competition because WhatsApp is not a “key distribution channel” for chatbots.

The dispute comes as Europe seeks to reduce its reliance on US technology companies by fostering homegrown alternatives. Europe accounted for roughly a quarter of Meta’s total advertising revenue last quarter, underscoring the region’s importance to the company’s business.

The case could test how far EU regulators are willing to go to prevent Big Tech firms from favoring their own AI tools inside widely used platforms — a stance that could ultimately reshape how AI services are distributed and monetized across Europe.

The dispute comes as Europe seeks to reduce its reliance on US technology companies by fostering homegrown alternatives. Europe accounted for roughly a quarter of Meta’s total advertising revenue last quarter, underscoring the region’s importance to the company’s business.

The case could test how far EU regulators are willing to go to prevent Big Tech firms from favoring their own AI tools inside widely used platforms — a stance that could ultimately reshape how AI services are distributed and monetized across Europe.

markets

AppLovin jumps after CapitalWatch announces “significant revisions” to negative report but says stance on company “remains unchanged”

AppLovin is trading to the upside on Monday morning after a financial research agency issued a “correction and apology” regarding some of the claims in its negative report on the company and its principals.

Shares of the ad tech firm tumbled in January as CaptialWatch called it “the ultimate monument to 21st-century new-type transnational financial crime.”

But after “a rigorous internal review,” CapitalWatch determined that the allegations of money laundering directed at one of AppLovin’s largest shareholders, Hao Tang, were based on a judicial document that was interpreted erroneously, and that his connections with other parties in the report “were inaccurate and failed to meet our publication standards.”

However, the outlet still argues that it’s right on the company, but just didn’t have enough evidence to single out Tang individually. Per CapitalWatch:

Our review concluded that while the macro data and transaction structures highlighted in the original report warrant market scrutiny, the information currently available is legally insufficient to attribute these complex capital operations directly and exclusively to Mr. Tang. We have chosen to retract the allegations directed at Mr. Tang personally out of strict adherence to evidentiary principles, not as a denial of the objective market phenomena observed.

Our stance regarding the complex financial structure of AppLovin (NASDAQ: APP) remains unchanged.

AppLovin forcefully denied the original report, saying it was “rife with false, misleading, and nonsensical allegations.”

The firm, like most in the software space, has floundered recently amid potential disruptive threats from AI tools and new entrants.

markets

Crypto-linked stocks slide as bitcoin tumbles back below $70,000

Bitcoin is back to singing the blues, pulling a host of crypto-adjacent stocks lower in premarket trading.

Strategy, MARA Holdings, Riot, and Coinbase are all down roughly 2% or more as of 5:50 a.m. ET.

The crypto asset rose 11.5% on Friday, its biggest daily gain since March 2023, and crept higher over the weekend before starting a sharp retreat overnight that’s carried forward through Monday morning.

Volatility in crypto has spiked relative to that of the US stock market. As of Friday’s close, realized 20-day annualized volatility for the iShares Bitcoin Trust was running 66 points above the SPDR S&P 500 ETF, the widest such premium since August 2024 and roughly double the average gap since the inception of the former fund in early 2024. In May 2025, the short-term volatility of SPY briefly exceeded that of IBIT amid the prior month’s tariff-induced plunge in stocks and start of the V-shaped recovery.

business

Hims to stop offering copy of Wegovy pill following FDA scrutiny

Hims & Hers said it has decided to stop offering its newly launched copycat version of Novo Nordisk’s Wegovy pill, after the telehealth company drew criticism from the Food and Drug Administration. 

“Since launching the compounded semaglutide pill on our platform, we’ve had constructive conversations with stakeholders across the industry. As a result, we have decided to stop offering access to this treatment,” Hims wrote on X.

Shares of Hims are down double digits in premarket trading on Monday, while Novo Nordisk ADRs are up more than 6% as of 5:20 a.m. ET.

On Friday afternoon, the FDA said it would take “decisive steps” to restrict GLP-1 compounding. Department of Health and Human Services General Counsel Mike Stuart said on social media Friday he had referred Hims to the Department of Justice “for investigation for potential violations by Hims of the Federal Food, Drug, and Cosmetic Act and applicable Title 18 provisions.”

Hims launched the product last week, a seeming copy of a recently released and patented drug, which immediately drew fire from Novo Nordisk and regulators.

Shares of Hims are down double digits in premarket trading on Monday, while Novo Nordisk ADRs are up more than 6% as of 5:20 a.m. ET.

On Friday afternoon, the FDA said it would take “decisive steps” to restrict GLP-1 compounding. Department of Health and Human Services General Counsel Mike Stuart said on social media Friday he had referred Hims to the Department of Justice “for investigation for potential violations by Hims of the Federal Food, Drug, and Cosmetic Act and applicable Title 18 provisions.”

Hims launched the product last week, a seeming copy of a recently released and patented drug, which immediately drew fire from Novo Nordisk and regulators.

markets

FDA says it will take “decisive steps” against GLP-1 compounders, HHS refers Hims to DOJ for investigation

The Food and Drug Administration said it would take decisive steps to restrict GLP-1 compounding, a day after Hims & Hers announced that it would sell copies of Novo Nordisk’s Wegovy pill.

The FDA specifically called out Hims in the announcement. Additionally, Department of Health and Human Services General Counsel Mike Stuart said in a post on X on Friday that he has referred Hims to the Department of Justice for investigation for potential violations by Hims of the Federal Food, Drug, and Cosmetic Act and applicable Title 18 provisions.

In a statement, Hims said the company has always operated with a deep commitment to the safety and best interests of consumers and in compliance with applicable law.

We have a long history of successfully working with regulators, and look forward to continuing to engage with the FDA to ensure safe access to affordable healthcare, they said.

This marks a significant shift in tone from the FDA, which has done little to prevent companies like Hims from marketing copies of Novos lucrative weight-loss drugs.

Shares of Hims fell 14% after-hours. The stock had already taken a hit after FDA Commissioner Marty Makary said in an X post on Thursday that the agency would “take swift action against companies mass-marketing illegal copycat drugs.”

The FDA specifically called out Hims in the announcement. Additionally, Department of Health and Human Services General Counsel Mike Stuart said in a post on X on Friday that he has referred Hims to the Department of Justice for investigation for potential violations by Hims of the Federal Food, Drug, and Cosmetic Act and applicable Title 18 provisions.

In a statement, Hims said the company has always operated with a deep commitment to the safety and best interests of consumers and in compliance with applicable law.

We have a long history of successfully working with regulators, and look forward to continuing to engage with the FDA to ensure safe access to affordable healthcare, they said.

This marks a significant shift in tone from the FDA, which has done little to prevent companies like Hims from marketing copies of Novos lucrative weight-loss drugs.

Shares of Hims fell 14% after-hours. The stock had already taken a hit after FDA Commissioner Marty Makary said in an X post on Thursday that the agency would “take swift action against companies mass-marketing illegal copycat drugs.”